Racura Oncology News and Activities

Racura Oncology is a company listed under the stock ticker RAC (AU).

View the org chart displaying its 10 main executives

Most searched biographies at Racura Oncology

• Daniel Tillett, Chief Executive Officer
• Peter Smith, Executive Chairman of the Board
• Megan Baldwin, Independent Non-Executive Director

Create your alert
to follow the executive moves at Racura Oncology.

Racura Oncology has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Racura Oncology

• GDPR Cookie Compliance – Cookie Banner, Cookie Consent, Cookie Notice – CCPA, DSGVO, RGPD
• News – Race Oncology

Social media about Racura Oncology

• Racura Oncology on Wikipedia, Google News & Yahoo Finance
• Racura Oncology on LinkedIn, X (Twitter) & YouTube